EyePoint Pharmaceuticals Inc.

EYPT | NASDAQ

$4.10

+$0.08 (+1.99%)

Sep 22, 2026, 1:20 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-231.96M	-130.87M	-70.8M	-102.25M	-58.42M	-45.39M
Depreciation & Amortization	2.31M	1.54M	464K	2.45M	2.77M	2.65M
Stock-Based Compensation	27.87M	36.74M	12.06M	14.18M	7.45M	5.55M
Other Working Capital	-28.28M	-34.86M	44.48M	-799K	-959K	16.62M
Other Non-Cash Items	-4.83M	-5.95M	1.18M	23.65M	628K	1.72M
Deferred Income Tax	279K	90K	83K	n/a	-787K	905K
Change in Working Capital	-33.78M	-27.77M	58.88M	-3.02M	-1.74M	20.14M
Operating Cash Flow	-240.11M	-126.23M	1.88M	-65.01M	-50.1M	-14.44M
Capital Expenditures	-3.28M	-4.05M	-3.48M	-2.15M	-156K	-362K
Cash Acquisitions	155K	n/a	-168K	-558K	n/a	n/a
Purchase of Investments	-252.02M	-398.3M	-55.12M	-139.12M	-32.97M	n/a
Sales Maturities Of Investments	318.9M	177.05M	55.28M	124M	n/a	n/a
Other Investing Acitivies	4.83M	5.95M	168K	558K	n/a	n/a
Investing Cash Flow	68.58M	-219.36M	-3.32M	-17.27M	-33.12M	-362K
Debt Repayment	-105K	-105K	-40.51M	2.1M	-146K	-11.8M
Common Stock Repurchased	n/a	n/a	n/a	-295K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.39M	813K	1.41M	-3.19M	223K	-624K
Financial Cash Flow	173.65M	164.02M	187.07M	-690K	216.9M	37.49M
Net Cash Flow	2.12M	-181.56M	185.63M	-82.96M	133.68M	22.7M
Free Cash Flow	-243.39M	-130.28M	-1.61M	-67.16M	-50.25M	-14.8M
Adj. Free Cash Flow	-271.26M	-167.02M	-13.67M	-81.33M	-57.7M	-20.34M
Maintenance CapEx	-3.28M	-4.05M	-2.81M	-1.61M	n/a	n/a
Growth CapEx	n/a	n/a	-671.48K	-542.72K	-156K	-362K
Owner Earnings	-243.39M	-130.28M	-936.53K	-66.61M	-50.1M	-14.44M